|Articles|February 20, 2008
L-acetylcarnitine Improves ADHD in Fragile X Syndrome
Treatment with L-acetylcarnitine may be beneficial in improving hyperactivity and social behavior in boys with fragile X syndrome who have attention-deficit/hyperactivity disorder (ADHD), according to an article published online Feb. 19 in the American Journal of Medical Genetics.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves centanafadine for ADHD in children, adolescents, and adults
2
Ensitrelvir now available in US for COVID-19 postexposure prophylaxis
3
Omalizumab outperforms multiallergen oral immunotherapy in multifood allergy trial
4
Pooled phase 3 data show early, consistent tapinarof cream responses across pediatric age groups in AD
5